Lipid disorders in uremia and dialysis
GL Bakris - Peritoneal Dialysis-State-of-the-Art 2012, 2012 - karger.com
Treatment of cholesterol in people with advanced stage chronic kidney disease (CKD)
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
Lipid disorders in uremia and dialysis.
GL Bakris - Contributions to Nephrology, 2012 - europepmc.org
Treatment of cholesterol in people with advanced stage chronic kidney disease (CKD)
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
Lipid Disorders in Uremia and Dialysis
GL Bakris - Peritoneal Dialysis: State-of-the-art 2012, 2012 - books.google.com
Abstract Treatment of cholesterol in people with advanced stage chronic kidney disease
(CKD) clearly reduces cardiovascular risk; however, it does not significantly slow …
(CKD) clearly reduces cardiovascular risk; however, it does not significantly slow …
Lipid disorders in uremia and dialysis
GL Bakris - Contributions to nephrology, 2012 - pubmed.ncbi.nlm.nih.gov
Treatment of cholesterol in people with advanced stage chronic kidney disease (CKD)
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
clearly reduces cardiovascular risk; however, it does not significantly slow nephropathy …
[引用][C] Lipid Disorders in Uremia and Dialysis
GL Bakris - Peritoneal Dialysis-State-of-the-Art 2012, 2012 - cir.nii.ac.jp
Lipid Disorders in Uremia and Dialysis
GL Bakris - Peritoneal Dialysis-State-of-the-Art 2012, 2012 - books.google.com
Abstract Treatment of cholesterol in people with advanced stage chronic kidney disease
(CKD) clearly reduces cardiovascular risk; however, it does not significantly slow …
(CKD) clearly reduces cardiovascular risk; however, it does not significantly slow …